8-K: Hims & Hers Health, Inc. Announces Results of 2024 Annual Stockholders Meeting

Hims & Hers Health, Inc. held its annual meeting on June 6, 2024, where stockholders voted on the election of directors, ratification of the company's accounting firm, and executive compensation.

Summary

• Hims & Hers Health, Inc. conducted its Annual Meeting of Stockholders on June 6, 2024.
• Stockholders voted on three proposals, which were detailed in the company's proxy statement filed on April 26, 2024.
• Only stockholders of record as of April 16, 2024, were eligible to vote.
• There were 206,271,215 shares of Class A common stock and 8,377,623 shares of Class V common stock outstanding and entitled to vote.
• Class A common stock holders had one vote per share, while Class V common stock holders had 175 votes per share.
• All proposals were voted on by both classes of stock as a single class.
• The first proposal was the election of eight directors, all of whom were elected.
• The second proposal was the ratification of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, which was approved.
• The third proposal was an advisory vote on the company's executive compensation, which was also approved.

Sentiment

Score: 7

Explanation: The document reports routine corporate governance matters with no significant positive or negative surprises. The sentiment is neutral to slightly positive due to the successful passing of all proposals.

Positives

• All proposed directors were successfully elected.
• The appointment of KPMG LLP as the independent auditor was ratified.
• The advisory vote on executive compensation was approved by the stockholders.

Management Comments

• Andrew Dudum, Chief Executive Officer, signed the report on behalf of the company.

Industry Context

This is a standard annual meeting report, typical for publicly traded companies, ensuring corporate governance and transparency with shareholders.

Comparison to Industry Standards

• The voting procedures and proposals are consistent with standard practices for publicly traded companies in the United States.
• The election of directors, ratification of auditors, and advisory vote on executive compensation are common agenda items for annual shareholder meetings.
• The detailed vote counts provided are in line with the transparency requirements of the SEC.

Stakeholder Impact

• Shareholders have exercised their voting rights on key corporate matters.
• The successful election of directors ensures continuity in the company's leadership.
• The ratification of the auditor provides assurance of financial oversight.

Next Steps

• The elected directors will serve until the 2025 annual meeting.
• KPMG LLP will serve as the company's independent auditor for the fiscal year ending December 31, 2024.

Key Dates

Keywords

Annual Meeting, Stockholders, Directors, KPMG, Executive Compensation, Voting, Proxy Statement, Corporate Governance